Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3342546 | Autoimmunity Reviews | 2008 | 5 Pages |
Abstract
A growing body of evidences reinforces the close link between systemic lupus erythematosus (SLE) and atherosclerosis which is due to traditional and nontraditional risk factors for cardiovascular diseases. It is now recognized that SLE has a particular pattern of dyslipoproteinemia characterized by low HDL levels and increased triglycerides, which is aggravated by flares. Multiple mechanisms can induce an altered lipoprotein metabolism in SLE such as cytokines produced during systemic inflammation, autoantibodies and therapy.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Jozélio Freire de Carvalho, Eloísa Bonfá, Eduardo Ferreira Borba,